UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                   Form 10-QSB

     (Mark  One)
(X)  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURTIES  EXCHANGE  ACT  OF  1934

For  the  quarterly  period  ended  March  31,  2003
                                    ----------------

(  ) TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934

For  the  transition  period  from                   to
                                    ---------------      ----------------
            COMMISSION FILE NUMBER                  0-30711
                                           -------------------------

                            SECURITY BIOMETRICS, INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

            Nevada                                          88-0209119
------------------------------                     -----------------------------
State  or  other  jurisdiction                     (IRS  Employer Identification
of  incorporation  or  organization                             No.)


1410  -  1030  West  Georgia  Street
Vancouver,  British  Columbia,  Canada,  V6E  2Y3
(Address  of  principal  executive  offices)

Issuer's  telephone  number:  (604)  609-7749



State the number of shares outstanding of each of the issuer's classes of common
stock  as  of  March  31,  2003

Common  Stock,  $.001  par  value                      122,403,807
---------------------------------                  ------------------
             Class                                 Number  of  shares


                                        1
<PAGE>

<TABLE>
<CAPTION>
                            SECURITY BIOMETRICS, INC.
                                      INDEX
                                      -----


PART I

Item 1
Financial Information                                Page No.
--------------------------------------------------  -----------
<S>                                                   <C>

Consolidated Balance Sheet March 31, 2003. . . . . . . .    3-4

Consolidated Statement of Comprehensive Loss for
 the three and nine month periods ended March 31,
 2003 & 2002 . . . . . . . . . . . . . . . . . . . . . .      5

Consolidated Statement of Operations for the three
 and nine months ended March 31, 2003 & 2002 . . . . . .      6

Consolidated Statement of Shareholders' Equity
 for the three and nine months ended March 31, 2003. . .      7

Consolidated Statement of Cash Flows for the
 three and nine months ended March 31, 2003 & 2002 . . .    8-9

Notes to Consolidated Financial Statements for the
 period ended March 31, 2003 . . . . . . . . . . . . . .  10-19

Item 2.
Management Discussion and Analysis of Results of
 Operations and Financial Condition. . . . . . . . . . .  19-22

Item 3.
Controls and Procedures.

Signatures . . . . . . . . . . . . . . . . . . . . . . .  23-24

</TABLE>


                                        2
<PAGE>

<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET

                                                      MARCH 31      JUNE 30
                                                        2003         2002
                                                     (Unaudited)  (Audited)
                                                    ------------  -----------
<S>                                                 <C>           <C>
CURRENT ASSETS
  Cash and cash equivalents. . . . . . . . . . . .  $          -  $   483,275
  Accounts and other receivable (Note 3) . . . . .       294,603      119,741
  Costs and estimated earnings in excess
     of billings on uncompleted contracts (Note 7)       154,124            -
  Inventory (Note 4) . . . . . . . . . . . . . . .       100,896       65,483
  Prepaid expenses . . . . . . . . . . . . . . . .       103,199      189,378
                                                    ------------  -----------
                                                         652,822      857,877
                                                    ------------  -----------



PROPERTY AND EQUIPMENT,
NET OF ACCUMULATED
DEPRECIATION  (NOTE 5) . . . . . . . . . . . . . .       192,951      241,550
                                                    ------------  -----------




OTHER ASSETS
  Goodwill (Note 6). . . . . . . . . . . . . . . .    10,922,798   10,933,298
  WonderNet, Ltd. Licensing Agreement. . . . . . .       187,500      187,500
  Deposits . . . . . . . . . . . . . . . . . . . .         6,522        5,874
                                                    ------------  -----------
TOTAL OTHER ASSETS . . . . . . . . . . . . . . . .    11,116,820   11,126,672
                                                    ------------  -----------

                                                    $ 11,962,593  $12,226,099
                                                    ============  ===========

</TABLE>


                                        3
<PAGE>
<TABLE>
<CAPTION>


SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET  (CONTINUED)


                                                                          MARCH 31      JUNE 30
                                                                            2003          2002
                                                                        (Unaudited)   (Audited)
                                                                        ------------  ------------
<S>                                                                     <C>           <C>
CURRENT LIABILITIES
  Bank overdraft . . . . . . . . . . . . . . . . . . . . . . . . . . .  $   198,269   $         -
  Accounts payable - non-related parties . . . . . . . . . . . . . . .      861,175       868,285
  Accounts payable - related parties . . . . . . . . . . . . . . . . .    1,034,281       287,857
  Accrued liabilities. . . . . . . . . . . . . . . . . . . . . . . . .      407,551       383,693
  Billings in excess of costs and estimated earnings on
    uncompleted contracts (Note 7) . . . . . . . . . . . . . . . . . .       64,446       541,245
  Corporate income taxes payable . . . . . . . . . . . . . . . . . . .      425,037       424,542
  Capital lease payable, current portion (Note 8). . . . . . . . . . .        5,230         5,230
  Notes payable, current portion (Note 9). . . . . . . . . . . . . . .    2,000,000     2,000,000
  Convertible debentures - current portion (Note 11) . . . . . . . . .    1,680,000     1,680,000
  Equipment loan, current portion  (Note 10) . . . . . . . . . . . . .        9,201        23,667
                                                                        ------------  ------------
TOTAL CURRENT LIABILITIES. . . . . . . . . . . . . . . . . . . . . . .    6,685,190     6,214,519
                                                                        ------------  ------------


LONG-TERM LIABILITIES
  Capital lease - long term portion (Note 8) . . . . . . . . . . . . .        2,764         6,411
  Equipment loan - long term portion (Note 10) . . . . . . . . . . . .        8,117         5,251
  Loan payable, non-interest bearing . . . . . . . . . . . . . . . . .        5,500             -
  Convertible debenture - long term portion (Note 11). . . . . . . . .      100,000       100,000
                                                                        ------------  ------------
TOTAL LONG-TERM LIABILITIES. . . . . . . . . . . . . . . . . . . . . .      116,381       111,662
                                                                        ------------  ------------


MINORITY INTEREST IN EQUITY OF CONSOLIDATED SUBSIDIARY (NOTE 12) . . .           77             -
                                                                        ------------  ------------


STOCKHOLDERS' EQUITY
COMMON STOCK
  Authorized - 300,000,000 shares
    $0.001 par value
  Issued and outstanding 122,403,807 shares. . . . . . . . . . . . . .      122,404       117,601
  Additional paid-in capital . . . . . . . . . . . . . . . . . . . . .    7,911,495     7,346,645
  Accumulated other comprehensive loss . . . . . . . . . . . . . . . .      (11,473)       (6,989)

  Accumulated deficit. . . . . . . . . . . . . . . . . . . . . . . . .   (2,861,481)   (1,557,339)
                                                                        ------------  ------------
TOTAL STOCKHOLDERS' EQUITY . . . . . . . . . . . . . . . . . . . . . .    5,160,945     5,899,918
                                                                        ------------  ------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY . . . . . . . . . . . . . .  $11,962,593   $12,226,099
                                                                        ============  ============

See Accompanying Notes to Unaudited Consolidated Financial Statements

</TABLE>


                                        4
<PAGE>
<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  COMPREHENSIVE  LOSS
(UNAUDITED)


                                              NINE MONTHS  NINE MONTHS
                                                 ENDED        ENDED
                                               MARCH 31,     MARCH 31
                                                  2003         2002
                                              ------------  ----------
<S>                                           <C>           <C>
NET LOSS . . . . . . . . . . . . . . . . . .  $(1,304,142)  $(846,680)
  OTHER COMPREHENSIVE LOSS
     Foreign currency translation adjustment       (4,484)     (2,211)
                                              ------------  ----------
NET COMPRENSIVE LOSS . . . . . . . . . . . .  $(1,308,626)  $(848,891)
                                              ============  ==========
</TABLE>

See Accompanying Notes to Unaudited Consolidated Financial Statements


                                        5
<PAGE>
<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  OPERATIONS
(UNAUDITED)


                                                         QUARTER       QUARTER      NINE MONTHS    NINE MONTHS
                                                          ENDED         ENDED          ENDED         ENDED
                                                        MARCH 31       MARCH 31      MARCH 31      MARCH 31,
                                                          2003           2002          2003           2002
                                                      -------------  ------------  -------------  ------------
<S>                                                   <C>            <C>           <C>            <C>
REVENUE
  Contract revenues earned . . . . . . . . . . . . .  $    302,680   $         -   $  1,209,791   $         -
  Penflow revenues . . . . . . . . . . . . . . . . .             -             -         56,561             -
  Datadesk sales . . . . . . . . . . . . . . . . . .        25,617             -        158,376             -
  Datadesk fees and royalties. . . . . . . . . . . .         6,070             -         82,783             -
                                                      -------------  ------------  -------------  ------------
TOTAL REVENUE. . . . . . . . . . . . . . . . . . . .       334,367             -      1,507,511             -
                                                      -------------  ------------  -------------  ------------

COSTS AND EXPENSES
  Cost of revenues earned. . . . . . . . . . . . . .       198,268             -        643,013             -
  Cost of sales. . . . . . . . . . . . . . . . . . .        10,800             -         95,720             -
  Bad debt . . . . . . . . . . . . . . . . . . . . .        20,000             -         20,000             -
  Depreciation . . . . . . . . . . . . . . . . . . .        17,412           705         52,575         2,406
  Selling, general and administrative. . . . . . . .       455,562       289,397      1,720,498       601,258
                                                      -------------  ------------  -------------  ------------
TOTAL COSTS AND EXPENSES . . . . . . . . . . . . . .       702,042       290,102      2,531,806       603,664
                                                      -------------  ------------  -------------  ------------
NET OPERATING LOSS . . . . . . . . . . . . . . . . .      (367,675)     (290,102)    (1,024,295)     (603,664)
   Interest expense. . . . . . . . . . . . . . . . .      (109,120)       (8,529)      (316,485)     (243,016)
   Gain on decrease in ownership of
   subsidiary. . . . . . . . . . . . . . . . . . . .        36,638             -         36,638             -
                                                      -------------  ------------  -------------  ------------
NET LOSS . . . . . . . . . . . . . . . . . . . . . .  $   (440,157)  $  (298,631)  $ (1,304,142)  $  (846,680)
                                                      =============  ============  =============  ============

NET LOSS PER COMMON SHARE
     Basic and diluted . . . . . . . . . . . . . . .  $      (0.00)  $     (0.00)  $      (0.01)  $     (0.01)
                                                      =============  ============  =============  ============

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING
     Basic and diluted . . . . . . . . . . . . . . .   121,920,366    78,154,436    120,174,338    73,244,343
                                                      =============  ============  =============  ============

</TABLE>

See Accompanying Notes to Unaudited Consolidated Financial Statements


                                        6
<PAGE>
<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  STOCKHOLDERS'  EQUITY
FOR  THE  NINE  MONTHS  ENDED  MARCH  31,  2003
(UNAUDITED)




                                                                                     ACCUMULATED
                                                  COMMON STOCK        ADDITIONAL       OTHER
                                            ----------------------     PAID IN      COMPREHENSIVE   ACCUMULATED
                                               SHARES      AMOUNT      CAPITAL          LOSS          DEFICIT        TOTAL
                                            ------------  --------  --------------  -------------  ------------  ------------
<S>                                         <C>           <C>       <C>             <C>            <C>           <C>
BALANCE, JUNE 30, 2002 . . . . . . . . . .   117,601,248  $117,601  $    7,346,645  $     (6,989)  $(1,557,339)  $ 5,899,918


ISSUANCE OF COMMON STOCK FOR:
  Cash (net of $20,148 finders' fees paid)     3,743,184     3,744         461,359             -             -       465,103
  Services . . . . . . . . . . . . . . . .     1,059,375     1,059         103,491             -             -       104,550

ACCUMULATED OTHER COMPREHENSIVE
INCOME FOR THE NINE MONTH PERIOD
ENDED MARCH 31, 2003 . . . . . . . . . . .             -         -               -        (4,484)            -        (4,484)

NET LOSS FOR THE NINE MONTH PERIOD
 ENDED MARCH 31, 2003. . . . . . . . . . .             -         -               -             -    (1,304,142)   (1,304,142)
                                            ------------  --------  --------------  -------------  ------------  ------------
BALANCE, MARCH 31, 2003. . . . . . . . . .   122,403,807  $122,404  $    7,911,495  $    (11,473)  $(2,861,481)  $ 5,160,945
                                            ============  ========  ==============  =============  ============  ============

</TABLE>

See  Accompanying  Notes  to  Unaudited  Consolidated  Financial  Statements


                                        7
<PAGE>
<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS
(UNAUDITED)

                                          QUARTER     QUARTER     NINE MONTHS   NINE MONTHS
                                           ENDED        ENDED        ENDED         ENDED
                                         MARCH 31,    MARCH 31,    MARCH 31,     MARCH 31,
                                           2003         2002          2003         2002
                                        -----------  -----------  ------------  -----------
<S>                                     <C>          <C>          <C>           <C>
CASH FLOWS FROM OPERATING
 ACTIVITIES:
  Net loss . . . . . . . . . . . . . .  $ (440,157)  $ (298,631)  $(1,304,142)  $ (846,680)
  Adjustment to reconcile net loss to
      net cash provided (used) by
      operating activities
      Depreciation . . . . . . . . . .      17,412          705        52,575        2,406
      Consulting services. . . . . . .           -            -       104,550            -
      Interest expense - beneficial
        conversion feature . . . . . .           -            -             -      233,333
      Gain on decrease in ownership of
      Subsidiary . . . . . . . . . . .     (36,638)           -       (36,638)           -
  Changes in operating assets and
        liabilities:
      Accounts and other receivable. .     (65,998)      (3,119)     (174,862)        (615)
      Inventory. . . . . . . . . . . .     (41,705)           -       (35,413)           -
      Prepaid expenses . . . . . . . .      28,295       (1,375)       86,179       (1,783)
      Deposit. . . . . . . . . . . . .        (648)           -          (648)           -
      Accrued liabilities. . . . . . .     (73,822)     (30,232)       23,858      (20,489)
      Accounts payable - non-related
        parties. . . . . . . . . . . .     247,738      116,718        (7,110)      96,590
      Corporation taxes payable. . . .      (4,665)           -           495            -
      Costs and estimated profits in
        excess of billings on
        uncompleted contracts. . . . .     (24,619)           -      (154,124)           -
      Billings in excess of costs and
        estimated earnings on
        uncompleted contracts. . . . .     (30,340)           -      (476,799)           -
                                        -----------  -----------  ------------  -----------
NET CASH USED BY OPERATING
ACTIVITIES . . . . . . . . . . . . . .    (425,147)    (215,934)   (1,922,079)    (537,238)
                                        -----------  -----------  ------------  -----------

CASH FLOWS FROM INVESTING
ACTIVITIES:
  Purchase of property & equipment . .      (3,651)           -        (3,976)      (3,792)
  Increase in trademark. . . . . . . .           -       (8,042)
  Decrease (increase) in goodwill. . .           -            -        10,500            -
                                        -----------  -----------  ------------  -----------
NET CASH PROVIDED (USED) BY
INVESTING ACTIVITIES . . . . . . . . .      (3,651)           -         6,524      (11,834)
                                        -----------  -----------  ------------  -----------

</TABLE>



                                        8
<PAGE>
<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS  (CONTINUED)
(UNAUDITED)
                                                               QUARTER     QUARTER    NINE MONTHS  NINE MONTHS
                                                                ENDED       ENDED        ENDED        ENDED
                                                               MARCH 31    MARCH 31    MARCH 31     MARCH 31
                                                                 2003        2002        2003         2002
                                                              ----------  ----------  -----------  ----------
<S>                                                           <C>         <C>         <C>          <C>
CASH FLOWS FROM FINANCING ACTIVITIES:
  Increase in bank overdraft . . . . . . . . . . . . . . . .    105,471           -      198,269           -
  Net proceeds from common stock . . . . . . . . . . . . . .    138,602           -      465,102     214,144
  Net proceeds from minority interest. . . . . . . . . . . .     36,715      36,715
  Proceeds from convertible debenture. . . . . . . . . . . .          -           -            -     100,000
  Payments on capital lease. . . . . . . . . . . . . . . . .     (1,130)        (31)      (3,647)     (1,089)
  Payments of equipment note . . . . . . . . . . . . . . . .     (3,713)          -      (11,600)          -
  Increase in loans payable. . . . . . . . . . . . . . . . .      5,500           -        5,500           -
  Increase in due to related parties . . . . . . . . . . . .    122,242     213,944      746,424     213,944
                                                              ----------  ----------  -----------  ----------
 NET CASH PROVIDED BY FINANCING ACTIVITIES . . . . . . . . .    403,687     213,913    1,436,763     526,999
                                                              ----------  ----------  -----------  ----------

EFFECT ON EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS     (2,698)      1,647       (4,483)     (2,211)
                                                              ----------  ----------  -----------  ----------

NET INCREASE (DECREASE)  IN CASH AND CASH EQUIVALENTS. . . .    (27,809)       (374)    (483,275)    (24,284)

CASH AND CASH EQUIVALENTS, AT BEGINNING OF PERIOD. . . . . .     27,809       2,236      483,275      26,146
                                                              ----------  ----------  -----------  ----------

CASH AND CASH EQUIVALENTS, AT END OF PERIOD. . . . . . . . .  $       -   $   1,862   $        -   $   1,862
                                                              ==========  ==========  ===========  ==========

SUPPLEMENTAL DISCLOSURE OF
   CASH FLOW INFORMATION

CASH PAID DURING PERIOD FOR:
      Interest . . . . . . . . . . . . . . . . . . . . . . .  $   5,512   $   7,081   $  212,877   $   9,683
                                                              ==========  ==========  ===========  ==========

      Taxes. . . . . . . . . . . . . . . . . . . . . . . . .  $       -   $       -   $        -   $       -
                                                              ==========  ==========  ===========  ==========

NON-CASH INVESTING AND FINANCIAL ACTIVITIES

ISSUANCE OF COMMON STOCK FOR:
       Services. . . . . . . . . . . . . . . . . . . . . . .  $       -   $       -   $  104,550   $       -
                                                              ==========  ==========  ===========  ==========

</TABLE>




See  Accompanying  Notes  to  Unaudited  Consolidated  Financial  Statements


                                        9
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS


NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

ORGANIZATION  AND  NATURE  OF  BUSINESS
---------------------------------------

SECURITY  BIOMETRICS,  INC.  AND  BIOMETRICS  SECURITY,  INC.

Security Biometrics, Inc. (hereinafter referred to as "the Company") is a Nevada
corporation  incorporated  on  March  12,  1999.

On August 25, 2000, the Company acquired all of the issued and outstanding stock
of  Biometrics Security, Inc. (hereinafter referred to as "BSI") in exchange for
38,257,675  shares  of  the  Company's common stock. (37,500,000 of these shares
were  owned by a trust whose beneficiaries were the children of a former officer
of  the  Company).  This transaction has the effect of what is commonly referred
to  as  a  "reverse  acquisition"  in  that  the  Company is the legal acquirer;
however,  BSI is the accounting acquirer.   In connection with the legal form of
this  transaction,  BSI  became  a  wholly-owned subsidiary of the Company.  For
accounting  purposes,  the  acquisition  is treated as a recapitalization of BSI
rather  than  a  business  combination.

BASIS  OF  PRESENTATION

The unaudited financial statements of the Company as at March 31, 2003 and 2002,
and  for  the  nine  months  ended March 31, 2003 and 2002 have been prepared in
accordance  with  accounting  principles generally accepted in the United States
for  interim reporting.  Accordingly, they do not include all of the disclosures
required  by  accounting  principles generally accepted in the United States for
complete  financial  statements and notes thereto included in the Company's Form
10-KSB  for  the  year  ended  June 30, 2002.  In the opinion of management, all
adjustments  (consisting  only  of  normal  recurring  adjustments)  considered
necessary for a fair presentation of the interim financial information have been
included.  The  results of operations for any interim period are not necessarily
indicative  of  the  results  of  operations  for  the  entire  year.

GOING  CONCERN

The  Company  experienced  significant  operating  losses  since  inception.  In
addition,  as  at  March  31,  2003,  the  Company has a working capital deficit
amounting  to  approximately $6.0 million. The consolidated financial statements
have  been  prepared  assuming  the  Company will continue to operate as a going
concern  which  contemplates  the  realization  of  assets and the settlement of
liabilities  in  the  normal course of business.  No adjustment has been made to
the  recorded  amount  of  assets  or  the  recorded amount or classification of
liabilities  which  would be required if the Company were unable to continue its
operations.  As  discussed  in Note 16, management has developed and is starting
to  implement  a financial reorganization plan which they believe should correct
the  present  financial  imbalance.

PRINCIPLES  OF  CONSOLIDATION

The  consolidated  financial  statements  include  the  accounts  of  Security
Biometrics,  Inc.  and  the  following  subsidiaries:
               Biometrics  Security,  Inc.
               Lightec  Communications  Corp.
               Datadesk  Technologies,  Inc.
               EMedRx,  Inc.
               NetFace,  LLC  (Inactive)

All  material  inter-company  accounts  and  transactions  have been eliminated.


                                       10
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS


NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

CASH  AND  CASH  EQUIVALENTS
----------------------------
For  purposes  of  the statement of cash flows, the Company considers all highly
liquid  debt  instruments purchased with an original maturity of three months or
less  to  be  cash  equivalents.

ACCOUNTING  ESTIMATES
---------------------
Management  uses  estimates  and assumptions in preparing consolidated financial
statements  in  accordance  with generally accepted accounting principles in the
United  States.  Those  estimates and assumptions affect the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities, and
the  reported  revenues  and  expenses.  Actual  results  could  vary  from  the
estimates  that  were  used.  Significant  estimates  used  in  these  financial
statements include fair values and impairment analysis of the Company's Property
and  Equipment,  Goodwill,  and  WonderNet,  Ltd.  Licensing  Agreement.

REVENUE  AND  COST  RECOGNITION
-------------------------------
LIGHTEC
-------
Lightec  recognizes  revenues  from  fixed-price  and  modified  fixed-price
construction  contracts  on the percentage-of-completion method, measured by the
percentage  of  cost incurred to date to estimated total cost for each contract.
This  method  is  used  because  management  considers total cost to be the best
available  measure  of  progress  on  the  contracts.  Because  of  inherent
uncertainties  in  estimating costs, it is at least reasonably possible that the
estimates  used  will  change  within  the  near  term.

Revenue from time-and-materials contracts is recognized currently as the work is
performed.

Contract  costs  include  all direct material and labor costs and those indirect
costs  related to contract performance, such as indirect labor, supplies, tools,
repairs,  and  depreciation.  Selling,  general  and  administrative  costs  are
charged  to expense as incurred.  Provisions for estimated losses on uncompleted
contracts  are  made in the period in which such losses are determined.  Changes
in  job  performance,  job conditions, and estimated profitability may result in
revisions  to  costs and income, which are recognized in the period in which the
revisions are determined.  Changes in estimated job profitability resulting from
job  performance,  job  conditions,  contract  penalty  provision, claims change
orders and settlements, are accounted for as changes in estimates in the current
period.

The  asset,  "Costs  and estimated earnings in excess of billings on uncompleted
contracts",  represents  revenues  recognized  in excess of amounts billed.  The
liability,  "Billings  in  excess of costs and estimated earnings on uncompleted
contracts",  represents  billings  in  excess  of  revenues  recognized.

Revenue  from  claims  is recognized when realization is probable and the amount
can  be reliably estimated.  When realization is probable, but the amount cannot
be  reliably  estimated,  revenue is recognized to the extent of costs incurred.

DATADESK
--------
Product  sales  -  when  goods  are  shipped  and  title passes to the customer.
Keyboard  development  fees  -  when  services  are  performed.
Royalties  -  when  the  licensee  sells the product and reports the sale to the
Company.

ACCOUNTS  RECEIVABLE
--------------------
Accounts receivable are reported at the customers' outstanding balances less any
allowance  for  doubtful  accounts, marketing credits and allowance for possible
sales  returns.



                                       11
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

ALLOWANCE  FOR  DOUBTFUL  ACCOUNTS, MARKETING CREDITS AND ALLOWANCE FOR POSSIBLE
--------------------------------------------------------------------------------
SALES  RETURNS
--------------
The  allowance  for doubtful accounts is charged to income in amounts sufficient
to  maintain  the  allowance at a level management believes is adequate to cover
any  possible  losses,  credits  or  returns.

INVENTORY
---------
Datadesk's inventory is stated at the lower of cost (determined on the first-in,
first-out  method)  or  market.

PROPERTY  AND  EQUIPMENT
------------------------
Property  and Equipment are stated at cost.  Major renewals and improvements are
charged to the asset accounts while replacements, maintenance and repairs, which
do  not  improve or extend the lives of the respective assets, are expensed.  At
the  time property and equipment are retired or otherwise disposed of, the asset
and  related  accumulated  depreciation  accounts are relieved of the applicable
amounts.  Gains  or  losses from retirements or sales are credited or charged to
income.

The  Company  depreciates  its  property  and  equipment for financial reporting
purposes using the straight-line method based upon the following useful lives of
the  assets:

               Furniture  and  fixtures            7-10  Years
               Machinery  and  equipment           5  Years
               Computer  equipment                 5  Years
               Vehicles                            5  Years

ACCOUNTING  FOR  CONVERTIBLE  DEBT  SECURITIES
----------------------------------------------
The  Company  has  issued  convertible  debt  securities  with  a non-detachable
conversion  feature  that were "in the money" at the date of issue.  The Company
accounts for such securities in accordance with Emerging Issues Task Force Topic
98-5.  The  Company  has  recorded  the  fair value of the beneficial conversion
feature  as  an  interest  expense  and  increase in Additional Paid-In Capital.

The  beneficial  interest  is computed by subtracting the stock conversion price
from  the  market  price  of  the  stock times the number of shares and warrants
eligible  for  conversion.

INCOME  TAXES
-------------
Provisions  for  income  taxes  are based on taxes payable or refundable for the
current  year  and deferred taxes on temporary differences between the amount of
taxable  income  and pretax financial income and between the tax basis of assets
and  liabilities  and  their  reported  amounts  in  the  financial  statements.
Deferred  tax assets and liabilities are included in the financial statements at
currently  enacted  income  tax  rates  applicable  to  the  period in which the
deferred  tax  assets  and liabilities are expected to be realized or settled as
prescribed  in  FASB Statement No. 109, Accounting for Income Taxes.  As changes
in  tax  laws  or  rates  are  enacted,  deferred tax assets and liabilities are
adjusted  through  the  provision  for  income  taxes.

NET  (LOSS)  PER  SHARE
-----------------------
The  Company  adopted  Statement  of Financial Accounting Standards No. 128 that
requires the reporting of both basic and diluted (loss) per share.  Basic (loss)
per share is computed by dividing net (loss) available to common stockholders by
the  weighted  average  number  of  common  shares  outstanding  for the period.
Diluted  (loss)  per  share  reflects the potential dilution that could occur if
securities  or other contracts to issue common stock were exercised or converted
into  common stock. In accordance with SFAS 128, any anti-dilutive effect on net
(loss)  per  share  are  excluded.


                                       12
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

LONG-LIVED  ASSETS
------------------
Statement  of  Financial  Accounting  Standards  No.  144,  "Accounting  for the
Impairment or Disposal of Long-lived Assets," requires that long-lived assets be
reviewed  for  impairment  whenever  events or changes in circumstances indicate
that  the  carrying amount of the asset in question may not be recoverable.  For
the  nine  month  period  ended  March  31,  2003,  this standard did not have a
material  effect on the Company's results of operations, cash flows or financial
position.

DISCLOSURE  ABOUT  FAIR  VALUE  OF  FINANCIAL  INSTRUMENTS
----------------------------------------------------------
The  Company  estimates  that  the fair value of all financial instruments as of
March  31,  2003,  as  defined  in FASB 107, does not differ materially from the
aggregate  carrying  values  of  its  financial  instruments  recorded  in  the
accompanying  balance  sheet.  The  estimated  fair  value  amounts  have  been
determined  by  the  Company  using available market information and appropriate
valuation  methodologies.  Considerable  judgment  is  required  in interpreting
market  data  to  develop  the  estimates  of  fair  value, and accordingly, the
estimates  are  not necessarily indicative of the amounts that the Company could
realize  in  a  current  market  exchange.

STOCK-BASED  COMPENSATION
-------------------------
The  Company  has  elected to account for stock-based compensation following APB
No.  25  "Account  for  Stock  Issued  to  Employees",  and  provides disclosure
requirements  under  SFAS  No.  123  "Accounting  for Stock-based Compensation".

FOREIGN  CURRENCY  TRANSLATION
------------------------------
The  financial  statements  of  the Company are measured using the United States
dollar  as  the functional currency.  Assets, liabilities and equity accounts of
the  Company  are  translated from foreign currency to United States currency at
exchange  rates  as  of  the  balance sheet date or historical acquisition date,
depending on the nature of the account.  Revenues and expenses are translated at
average  rates  of exchange in effect during the year.  The resulting cumulative
translation  adjustments  have  been  recorded  as  a  separate  component  of
stockholders'  equity.

SHIPPING  AND  HANDLING  COSTS
------------------------------
The  Company's policy is to classify shipping and handling costs as part of cost
of  goods  sold  in  the  statement  of  operations.

NOTE  2                  CASH  IN  BANK

     The  Federal  Deposit  Insurance  Corporation  and  the Securities Investor
Protection Corporation insure up to $100,000 for approved deposits in registered
financial  institutions.  The  Company  had  no  uninsured deposits at March 31,
2003.

NOTE  3     ACCOUNTS  AND  OTHER  RECEIVABLE

A  summary  of  accounts  and  other  receivable  is  as  follows:

Account receivable                                            $          268,624
Less: allowance for doubtful accounts, sales returns,
  and advertising incentives                                             (8,250)
                                                                         260,374
                                                              ------------------
Tax credits recoverable                                                    3,474
Stock subscription receivable                                             30,755
                                                              ------------------
Total accounts and other receivable                           $          294,603
                                                              ==================


                                       13
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  4     INVENTORY
Inventory  is  comprised  of  the  following:


  Finished goods                                               $          52,416
  Raw materials                                                           52,480
                                                                ----------------
                                                                         104,896
  Allowance for inventory obsolescence                                   (4,000)
                                                                ----------------
Total inventory                                                 $        100,896
                                                                ================

NOTE  5     PROPERTY  AND  EQUIPMENT

Property  and  equipment  and  accumulated  depreciation  consists  of:


  Furniture and fixtures                                     $            98,157
  Machinery and equipment                                                125,680
  Computer equipment                                                     102,431
  Vehicles                                                                77,657
                                                              ------------------
                                                                         403,925
  Less accumulated depreciation                                          210,974
                                                              ------------------
Total property and equipment                                  $          192,951
                                                              ==================


NOTE  6           GOODWILL

The  Company adopted the provisions of FASB 142 for the accounting for goodwill.
According  to  the FASB requirements, goodwill is capitalized and not amortized.
Each  fiscal  year,  management  is  required to review goodwill to determine if
there  has  been  an  impairment  loss  to  recognize  on  the carrying value of
goodwill.  Management  believes  that  there  has been no significant event that
would  impair  the goodwill for the nine months ended March 31, 2003.   However,
when the Company completes implementation of some of the actions included in the
financial  reorganization  plan  (See  note  16),  this  may affect the goodwill
carrying  value.


Goodwill  is  comprised  of  the  following:

The  excess  of  the  cost  of  an  acquired  entity over the net of the amounts
assigned  to  assets  acquired  and  liabilities  assumed  for:

          Lightec                                                $     7,527,653
          Datadesk                                                     3,395,145
                                                                 ---------------

                                                                 $    10,922,798
                                                                ================


                                       14
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS


NOTE  7          ESTIMATED  EARNINGS  ON  UNCOMPLETED  CONTRACTS


<TABLE>
<CAPTION>
                                                                             CONTRACT #1   CONTRACT #2
<S>                                                                          <C>           <C>
Cumulated costs incurred on uncompleted contracts . . . . . . . . . . . . .  $    183,036  $     38,227
Estimated earnings. . . . . . . . . . . . . . . . . . . . . . . . . . . . .       143,814        11,419
                                                                             ------------  ------------
                                                                                  326,850        49,646

Less: Billings to date. . . . . . . . . . . . . . . . . . . . . . . . . . .       172,726       113,978
                                                                             ------------  ------------

Costs in excess of billings on uncompleted contracts. . . . . . . . . . . .  $    154,124  $          -
                                                                             ============  ============

Billings in excess of costs and estimated earnings on uncompleted contracts  $          -  $     64,332
                                                                             ============  ============
</TABLE>


NOTE  8     CAPITAL  LEASE  PAYABLE

The  Company  acquired an office copier on a capital lease with National Leasing
Group,  Inc.  The  lease  requires monthly payments of approximately $300 for 48
months  including  interest  at  11%.  Future  minimum  payments are as follows:

                                             December  31,  2003     $     5,230
                                             December  31,  2004           2,764
                                                                     -----------
                           Total  minimum  lease  payments                 7,994
                           Less  amount  representing  interest            1,557
                                                                     -----------

                           Present value of minimum lease payment    $     6,437
                                                                     ===========


                                       15
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS


NOTE  9     NOTES  PAYABLE

<TABLE>
<CAPTION>



                                                                                     MARCH 31
                                                                                       2003
                                                                                    ----------
<S>                                                                                 <C>
MARYANNE RICHARD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $1,000,000

On  June  13, 2002, the Company issued a note payable to Maryanne Richard in the
amount  of  $1,000,000 as part of the consideration for the purchase of LIGHTEC.
The note bears interest at 9% and currently requires $250,000 principal payments
on  December  31,  2002,  March 31, 2003 and a final 500,000 payment on June 30,
2003.  The  note is secured by deposit accounts, investment property, letters of
credit  rights  and  letters  of credit, rights to payments evidenced by chattel
paper,  rights  to payments for money or funds advanced or sold and all proceeds
of  any and all of the above. The collateral for this security at March 31, 2003
amounted  to  $437,099.  The  security  is co- equal in priority to the security
granted  for  the  $1,000,000  note  payable to Synergex Group. Consideration of
8,000,000  share  purchase  warrants,  which  gives  the rights to the holder to
acquire one share of common stock at a price of 0.125 for a period of two years,
was  given to extend the repayment terms by three months to commence on December
31,  2002.  The  granting  of  share  purchase  warrants  is  subject to Lightec
obtaining  funding on the Bridgeport contract. As of the date of this statement,
the  Company  has  defaulted  the  repayments starting December 31, 2002 and the
Bridgeport contract has yet to be funded, consequently, interest payments on the
loan  are  currently  in  arrears

SYNERGEX GROUP PARTNERSHIP. . . . . . . . . . . . . . . . . . . . . . . . . . . .    1,000,000

On  June  11,  2002, Synergex Group Partnership loaned the Company $1,000,000 to
facilitate  the  acquisition  of  Lightec.  The  note  bears  interest at 9% and
currently  requires  $250,000  principal payments on, December 31, 2002, January
31,  2003,  February 28, 2003 and March 31, 2003. The note is secured by deposit
accounts,  investment  property, letters of credit rights and letters of credit,
rights  to  payments evidenced by chattel paper, rights to payments for money or
funds  advanced  or  sold  and  all  proceeds  of  any and all of the above. The
collateral  for  this  security  at  March  31,  2003  amounted to $437,099. The
security is co-equal in priority to the security granted for the $1,000,000 note
payable  to  Mary  Anne  Richard.  Consideration  of  8,000,000  share  purchase
warrants,  which  gives  the rights to the holder to acquire one share of common
stock  at  a  price of $0.125 for a period of two years, was given to extend the
repayment  terms  by three months to commence on December 31, 2002. The granting
of  share  purchase  warrants  is  subject  to  Lightec obtaining funding on the
Bridgeport contract. As of the date of this statement, the Company has defaulted
the repayments starting December 31, 2002 and the Bridgeport contract has yet to
be funded, consequently, interest payments on the loan are currently in arrears.

                                                                                    $2,000,000
                                                                                    ==========
</TABLE>


                                       16
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  10     NOTES  PAYABLE,  EQUIPMENT


Payable  to  General  Motors  Acceptance  Corporation,  secured  by two 2001 GMC
Savanas  with  original  costs  of  $46,864; payable for 36 months at $1,316 per
month including interest at 4.9%.

                                                              $           17,318
                                     Less  current  portion                9,201
                                                              ------------------
                                     Long-term  portion       $            8,117
                                                              ==================

                Principal  maturities  are  as  follows:
                December  31,  2003                           $            9,201
                December  31,  2004                                        8,117
                                                              ------------------
                                                              $           17,318
                                                              ==================

NOTE 11     CONVERTIBLE DEBENTURE PAYABLE

<TABLE>
<CAPTION>
<S>                                                                <C>
LIBRICO PROPERTIES, LTD.. . . . . . . . . . . . . . . . . . . . .  $  100,000

On November 8, 2001, the Company issued a convertible
debenture to Librico Properties, Ltd. for a minimum of
100,000 to a maximum of $1,000,000.

The debenture is unsecured, bears interest at 12% and
matures on November 2, 2011.

Librico Properties, Ltd. has the option, in whole or in part, to
convert the debenture into the Company's common stock at a
conversion price of $0.33 per share, subject to anti-dilution
adjustments. Because the interest payments on the loan are
currently in arrears, the Company has breached the loan
agreement; therefore, it is in default.

EDINBURGH INVESTMENTS LLC . . . . . . . . . . . . . . . . . . . .   1,680,000

On June 30, 2002, the Company issued a convertible
debenture to Edinburgh Investments LLC.  The debenture is
unsecured, matures on June 30, 2003 and accrues interest at
 10% payable quarterly.  Edinburgh has the option to convert
 the debenture into the Company's common stock at a
conversion price of $0.30 per share, subject to anti-dilution
adjustments. Because the interest payments on the loan are
currently in arrears, the Company has breached the loan
agreement; therefore it is in default.
                                                                   ----------
                                                                    1,780,000
                Less current portion. . . . . . . . . . . . . . .   1,680,000
                                                                   ----------
                Long-term portion . . . . . . . . . . . . . . . .  $  100,000
                                                                   ==========

Future maturities on the long-term debt are as follows:
                    June 30, 2003 . . . . . . . . . . . . . . . .  $1,680,000
                    November 2, 2011. . . . . . . . . . . . . . .     100,000
                                                                   ----------
                                                                   $1,780,000
                                                                   ==========
</TABLE>


                                       17
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  12     BUSINESS  ACQUISTION

On  January  21,  2003,  the Company incorporated a new wholly-owned subsidiary,
eMedRx,  Inc.  ("eMedRx")  under  the  Company  Act  of  the Province of British
Columbia,  Canada.  eMedRx  entered into an exclusive license agreement with the
Company  to develop and market its electronic medical prescription system around
the  world.  During  the  period  ended, March 31, 2003, eMedRx received $36,715
from new minority shareholders, which reduced the Company's investment in eMedRx
to less than 100%.  This resulted in a gain on disposal of subsidiary of $36,638
and  an  increase  in  minority  interest  of  $77.

NOTE  13       STOCK  WARRANTS  AND  OPTIONS

1.  The  company  has  the  following  warrants  outstanding:

<TABLE>
<CAPTION>
                                   NUMBER OF       PRICE         EXPIRATION
                                     SHARES       PER SHARE         DATE
                                   ----------  ---------------  -------------
<S>                              <C>          <C>              <C>
                                   7,083,333*   $     0.35      June 13, 2005
                                     991,666    $     0.15      November 12, 2003
</TABLE>


  *  The  Company has the right to force the conversion of those warrants if the
stock  price  of the Company's common stock exceeds $1.20 per share for a ninety
day  period.

2.  The  Company  has  agreed  to issue additional warrants in consideration for
extension  agreements on notes payable for 16,000,000 shares at $0.125 per share
for  a  period  of  two  years.  (see  Note  9)

3.  The  company  has  the  following  stock  options  outstanding:

<TABLE>
<CAPTION>
                                   NUMBER OF       PRICE         EXPIRATION
                                     SHARES       PER SHARE         DATE
                                   ----------  ---------------  -------------
<S>                              <C>          <C>              <C>
                                   5,859,091    $0.11 to $0.20  April 29 through
                                                                December 31, 2004
</TABLE>


4.  Other  commitments  to  issue  additional  common  shares:
On  April  3,  2002,  the  Company entered into a consultant agreement with Ladi
Corp.  The  agreement  provides  that  Ladi Corp. will receive 250,000 shares of
common  stock  if  the  Company's common stock closes at an average ask price of
$.50  per  share for a period of five consecutive days and an additional 250,000
shares  of common stock if the Company's common stock closes at an average price
of  $1.00  per  share  for  a  period  of  five  consecutive  days.


NOTE  14     STOCK  SUBSCRIPTIONS

The following schedule summarized the features and status of the current private
placement  offering:

Total  offering             3,000,000  stocks  at  $1,500  per  unit  ($450,000)
Private  placement unit     Each unit consists of 10,000 stocks and 10,000 stock
                            purchase warrants, each warrant entitling its holder
                            to purchase an additional share  at  $0.15  for  a
                            period of 12 months after the private placement
                            closes.
Status as of March 31, 2003 26.5 units sold raising $265,250 funds less $20,148
                            finder's  fees  paid.
The  stock  proceeds  have  been  included  with  stockholders  equity.


                                       18
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  15     BUSINESS  SEGMENTS

SFAS  Statement No. 131, "Disclosure about Segments of an Enterprise and Related
Information",  requires  companies  to  provide  certain information about their
operating  segments.  The  Company  has  three  reportable  segments:  Security
Biometrics,  Lightec  and  Datadesk.

Summarized  financial  information, concerning the Company's reportable segments
for  nine  months  ended  March  31,  2003,  is  shown  on  the following table:

<TABLE>
<CAPTION>
                                   SECURITY BIOMETRICS     LIGHTEC     DATADESK      TOTAL
                                   -------------------   ----------   ----------  ------------
<S>                               <C>                    <C>          <C>         <C>
Net sales to external companies.  $             56,562   $1,209,792   $ 241,159   $ 1,507,511
Operating earnings (loss). . . .            (1,040,869)     360,881    (344,307)   (1,024,295)
Total assets . . . . . . . . . .            11,347,458      499,939     115,196    11,962,593
Depreciation and amortization. .                 6,192       38,527       7,856        52,575
Capital expenditures . . . . . .                 2,876       (3,012)      4,113         3,977
</TABLE>


NOTE  16           MANAGEMENT'S  PLANS

The  Company  has  a  $6,032,368  working capital deficit of which approximately
$1,034,000  is owed to related parties, and $2,158,333 is owed to two directors.
The  $2,158,333  is  secured  by  notes payable as outlined in Note 9 above. The
Company  has developed and is implementing a financial reorganization plan which
is intended to result in a substantial realignment such that the Company's major
creditors  will release the Company's obligations on their debts, in return, the
Company  will  give-up  its  claim  on  the  future  cash flows from the Lightec
Communications'  uncompleted contracts (estimated gross profit of $3.6 million).
The Company also is negotiating with its related-party members to exchange their
debts  for  partial cash and its common stocks.  The Company has made noticeable
progresses  in  the  marketing  of  its  PenFlow  technology  and  expects these
progresses to continue with the corresponding favorable impact on its ability to
generate  cash.  Furthermore,  the  Company has formed a new subsidiary, eMedRx,
Inc. to develop and market its electronic medical prescription system throughout
the world and is also attempting to raise independent financing for eMedRx, Inc.
(See  Note 12), while the Company plans to raise additional capital primarily by
way  of  equity.


                                       19
<PAGE>

ITEM  2.     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATIONS

OVERVIEW

     Currently  the  company  has  a  negative  working  capital  deficit  of
approximately  $6.0  million.  The  Company  has  entered  into  a memorandum of
understanding  with  its  major  creditors  for  forgiveness of   their debts in
exchange  for  an  assignment  of the expected profit from the Bridgeport School
District  contract.


The  sales  outlook  for  the Company continues to improve. Security Biometrics,
Inc.  has  signed  several major agreements for the integration of the Company's
core  Penflow  biometric  signature  authentication  software.

The  research  and  development  programs  continue to expand. A new subsidiary,
eMedRx,  Inc.  has  been  incorporated  to  develop  software  for the medical /
pharmaceutical  industry.

When  used  in  this Form 10-QSB, the words "anticipated", "estimate", "expect",
and  similar  expressions  are  intended to identify forward-looking statements.
Such  statements  are  subject  to  certain risks, uncertainties and assumptions
including the possibility that we will fail to generate planned revenues. Should
one  or  more  of these risks or uncertainties materialize, or should underlying
assumptions  prove  incorrect,  actual  results  may  vary materially from those
anticipated,  estimated  or  projected.

The  following  discussion  and  analysis of financial conditions and results of
operation  should  be  read  in  conjunction  with  our  consolidated  financial
statements  and  notes  thereto  included  elsewhere  in  this  Form  10-QSB.

History
-------

Security  Biometrics, Inc. was incorporated as Great Bear Resources, Inc. in the
State  of  Nevada  on  March  12,  1999  and  we  changed our name to Great Bear
Investments,  Inc.  on  May 25, 1999. On August 11, 2000, we changed our name to
Security  Biometrics,  Inc.  We were a development stage company whose objective
was  to  develop  and  market  under  license  and  distribute dynamic biometric
technologies  specific  to  the  security  applications of banking and financial
transactions,  including  dynamic  gesture  recognition  technology,  dynamic
signature  verification  and  voice  recognition.

On  August  22,  2000,  we entered into an option agreement with DSI Datotech of
Vancouver,  Canada. The exercise price of the option was $8,000,000, of which we
paid  $320,000.  On June 29, 2001, we acquired all of the outstanding membership
interests  of NetFace, LLC, a Connecticut limited liability company, in exchange
for  20,000,000 share of our common stock. NetFace holds an option to acquire an
exclusive  worldwide,  perpetual,  royalty-free license to exploit DSI's gesture
recognition  technology  for  video  games and Internet/television. The exercise
price  of the option is $5,000,000 plus a 20% Class B Membership of NetFace LLC.
During  the year ended June 30, 2002, it was decided to abandon our interests in
DSI's  technology.

On  April  20,  2002, the Company entered into an exclusive rights and licensing
distribution and partnership agreement with WonderNet Ltd. of Israel. Under this
agreement,  we became the exclusive distributor for North America, the Caribbean
and  Mexico  of  WonderNet's  Penflow(TM)  patented  and  proprietary  Biometric
Signature  Authentication  ("BSA") software engine, which consists of a database
of  user  profiles  and enable remote and local access to the database using the
internet,  smart cards, or LAN connections to verify signatures by comparison to
signatures  in  the  database.  To  acquire  these  rights,  the  company issued
WonderNet  2,500,000  shares of common stock and agreed to pay WonderNet a 5 per
cent  royalty  on  products  sold.

The  agreement  with WonderNet allows the company to commence sub-licensing, and
marketing  a  proven  biometric  security  product.  We  have  decided to not to
exercise  our  options  with DSI Datotech at this time as we do not believe that
the  prototypes delivered to us are market ready at this time. Consequently, the
Company  expensed $320,000 in 2001 and the balance of the investment of $200,000
in  2002.


                                       20
<PAGE>

In  order  to  assist  in  the  development  and  support of providing biometric
security  solutions,  we  entered  into an agreement effective March 14, 2002 to
acquire  the  issued  and outstanding shares of Lightec Communications, Corp. of
Pleasant  Valley,  New  York.  Lightec  is  a  provider  of  high  quality
telecommunications  design,  installation  and  information technology services.
Lightec  was  established  in  1994  and  provides  quality  network  design,
installation,  and  maintenance  of  internal  building,  campus-wide,  local,
metropolitan and wide area network systems, primarily in the northeastern United
States.  On June 14, 2002, we closed the agreement to acquire Lightec by issuing
19,000,000  shares  of common stock and paying $4,000,000 in cash. In connection
with  this  acquisition,  we issued 4,000,000 shares of common stock and accrued
$200,000 as finder's fees under a finder's fee agreement with our Executive Vice
President,  Mr.  Chris  Farnworth.

On  June  28,2002,  we  entered  into  an  agreement  to  acquire the issued and
outstanding  shares  of  Datadesk  Technologies,  Inc.  of  Seattle, Washington.
Datadesk  is  in  the  business of designing, manufacturing, and selling desktop
solutions,  educational  computing  systems,  and handheld and wireless devises.
Datadesk was established in 1997 and provides high quality keyboards, peripheral
devises,  and  educational  systems. On June 28,2000, we closed the agreement to
acquire Datadesk Technologies, Inc. by issuing 10,999,951 shares of common stock
and  by  lending  $1,260,200  cash  to  Datadesk.

Until  the  acquisition of Lightec, we were a development stage company.   As of
March  14,  2002,  with  the  acquisition of Lightec we have become an operating
company.  During  the nine months ended March 31, 2003 ("YTD2003"), our net loss
was  $1,304,000  as  compared  to a $847,000 loss incurred during the nine month
period  ended  March  31,  2002  ("YTD2002"),  as  explained  in  the results of
operations.

Refinancing
-----------

The  Company  has  entered  into  a Memorandum of Understanding with certain its
larger  creditors.  This Memorandum is still subject to further negotiations and
other  conditions but it is anticipated that the final contract will be executed
in the near future. Under this Memorandum Synergex, Edinburgh, Maryanne Richard,
Michael  Richard  and  David  Faust have agreed to accept the assignment profits
from  the Bridgeport School District contract now held by Lightec Communications
Corp,  for  a  complete  release  of  all moneys due to them by the Company. The
current  debt  to  insiders  is  also  being  negotiated  for  partial  cash and
conversion  to equity. This will eliminate approximately $5.1 million of debt of
the  Company.

Research  and  Development
--------------------------

The  Company  formed  a  new company, eMedRx, Inc. in March 2003. The purpose of
this  company  is  to  develop  a  secure  system of electronically transmitting
medical  prescriptions  from  a  doctor  to  a pharmacy. A key component to this
technology  will  be  the  Penflow  technology  the  Company  already  licenses.
Although  the  company  believes this new technology would easily gain access to
the market place on its own, the anticipated changes to the HIPPA laws requiring
more  medical privacy will greatly increase the Company's sales potential. It is
anticipated  that  the  development  costs  of  the  Company will be financed by
outside  parties  in  exchange  for  equity  positions  in  eMedRx.

The  Company  is  in  process  of  consolidating  the operations of its Datadesk
Technologies  division  to  the Company's Vancouver office to enable the company
resources  to concentrate on its Penflow technology solutions and eMedRx medical
/  pharmaceutical  technologies.

Sales
-----

The  Company is continuing to sign agreements with VAR's (Value Added Resellers)
and System Integrators for sales of its Penflow technology. In the meantime, the
Company  is  actively  pursuing  new  leads  to  expand  its  customer  base.

Critical  Accounting  Policies
------------------------------

Our discussion and analysis of our financial condition and results of operations
are  based  upon  our  consolidated  statements,  which  have  been  prepared in
accordance  with  accounting principles generally accepted in the United States.
The  preparation of these financial statements requires us to make estimates and
judgments  that affect the reported amounts of assets, liabilities, revenues and
expenses.  In  consultation  with our Board of Directors and Audit Committee, we


                                       21
<PAGE>

have  identified  two  accounting  policies  that  we  believe  are  key  to  an
understanding  of  our  financial  statements.  These  are  important accounting
policies  that  require  management's  most  difficult,  subjective  judgments.

The  first  critical  accounting  policy  relates  to  revenue  recognition.  We
recognize  revenue  form  product  sales  upon shipment to the customer. License
revenues  are recognized when earned, in accordance with contractual provisions.
Royalty  revenues  are  recognized  upon  shipment of products incorporating the
related technology by the original equipment manufacturers (OEMs) and foundries.

The  second  critical  accounting  policy  relates  to  intangible  assets.  Our
intangible  assets  consist  primarily of goodwill. In accordance with SFAS 142,
"Goodwill  and  Other  Intangible  Assets," only intangible assets with definite
lives  are  amortized.  Non-amortized  intangible  assets are instead subject to
annual  impairment  testing.

 RESULTS  OF  OPERATIONS  YTD2003  AS  COMPARED  TO  YTD2002

         During  the  YTD2003, we have acquired Lightec Communications Corp. and
Datadesk  Technologies,  Inc.,  accordingly,  YTD  2003  results incorporate the
financial  results  of Lightec and Datadesk. Comparative numbers for YTD 2002 do
not  reflect the results of these subsidiaries. The following schedule highlight
and  provides  explanations to the significant changes incurred during the year:

<TABLE>
<CAPTION>
                                   Increase
                                  (decrease)
Income Statement Item          comparing year to                             Explanation
                               year and quarter
                                  to quarter
---------------------------    ------------------   --------------------------------------------------------------------
<S>                         <C>                  <C>
Contract revenues earned           $    1,210,000   Billings made in excess of costs and expected
                              Q3 - $      303,000   profits totaling $541,000 were realized during
                                                    YTD2003. In the most recent contract,approximately  4.5%  of  the
                                                    work  has  been completed on a $7.9 million dollar contract.
                                                    327,000  has  been  recognized  as revenue under this contract during
                                                    YTD2003,  while  only $173,000 has been to the client. Most of this
                                                    contract was recognized  during  Q2  and  Q3.
---------------------------    ------------------   --------------------------------------------------------------------
Pen flow sales                     $       37,000   Represents revenues from sale of Penflow
                              Q3 - $          Nil   Products and licensees.  However, recognized
                                                    20,000 as bad debt on the sales during the 3Q.
---------------------------    ------------------   --------------------------------------------------------------------
Datadesk sales and royalties       $      241,000   Represent revenues by Datadesk. The keyboard
                              Q3 - $       32,000   sales were $26,000 in Q3 versus $30,000 in Q2.
                                                    Decreasing revenue from keyboard sales reflect
                                                    the management's intent to wind-down the
                                                    keyboard business. Royalties from license
                                                    agreements were $6,000 in Q3 versus $32,000 in
                                                    Q2.  Furthermore, there were $6,000 in
                                                    Development fees in Q3 while no Development
                                                    fees were incurred during Q2.
---------------------------    ------------------   --------------------------------------------------------------------
Cost of revenues earned            $      643,000   Direct expenses incurred earning Lightec revenues
                              Q3 - $      198,000
---------------------------    ------------------   --------------------------------------------------------------------
Cost of sales                      $       96,000   Represent direct costs of Datadesk sales
                              Q3 - $       11,000
---------------------------    ------------------   --------------------------------------------------------------------
Interest expense                   $       73,000   Comparing YTD2003 to YTD2002 interest costs
                              Q3 - $       101,00   increased to $316,000 from $243,000. Of the
                                                    243,000 expensed in YTD2002, $233,000 was
                                                    due to a beneficial conversion provision in a
                                                    convertible debenture issued. The increase is due
                                                    to $3.8 million in loans outstanding as at 2003 YTD.
</TABLE>


                                       22
<PAGE>

<TABLE>
<CAPTION>
                                   Increase
                                  (decrease)
Income Statement Item          comparing year to                             Explanation
                               year and quarter
                                  to quarter
---------------------------    ------------------   --------------------------------------------------------------------
<S>                         <C>                  <C>
Selling, general &
administrative as follows:
------------------------------------------------------------------------------------------------------------------------
- Communication costs              $      103,000   Comparing YTD2003 to YTD2002, Communication
                              Q3 - $       27,000   costs increased to $154,000 from $51,000. This
                                                    increase is due to costs of 3 offices versus 1 during
                                                    prior year.
---------------------------    ------------------   --------------------------------------------------------------------
- Employee costs                   $      211,000   Comparing YTD2003 to YTD2002, Employee costs
                              Q3 - $        2,000   increased to $482,000 from $291,000. The
                                                    increase was due to the addition of the Lightec and
                                                    Datadesk operations.
---------------------------    ------------------   --------------------------------------------------------------------
- Investor relations               $      240,000   There was little investor relation activities during the
                              Q3 - $       11,000   previous year. Most of the current investor relation
                                                    expenditures are for consulting, most of which was
                                                    paid for by way of issuance of stock.
---------------------------    ------------------   --------------------------------------------------------------------
- Marketing                        $       29,000   Marketing costs of Security Biometrics, Inc and
                              Q3 - $       (7,000)  Datadesk products. There were $24,000 marketing
                                                    costs in 2002 YTD.
---------------------------    ------------------   --------------------------------------------------------------------
- Office                           $       41,000   Comparing YTD2003 to YTD2002, Office costs
                              Q3 - $       (4,000)  increased to $127,000 from $86,000. Increased
                                                    office expenses due to costs of keeping 3 offices'
                                                    supplied and operating.
---------------------------    ------------------   --------------------------------------------------------------------
- Consulting                       $      348,000   There were no consulting expenses incurred during
                              Q3 - $      138,000   the previous year. The Increase due to effect of
                                                    hiring CEO, CFO, Executive VP and Corporate
                                                    Secretary.
---------------------------    ------------------   --------------------------------------------------------------------
- Regulatory costs                 $       23,000   Due to costs of Edgar filings. There was only minor
                              Q3 - $        5,000   regulatory expenditures in YTD2002.
---------------------------    ------------------   --------------------------------------------------------------------
- Research and development         $       76,000   Increase is due to Datadesk R&D work primarily on
                              Q3 - $        9,000   eMedRx, Inc. compared to prior year.
---------------------------    ------------------   --------------------------------------------------------------------
- Legal                            $      (26,000)  Comparing YTD2003 to YTD2002, Legal costs
                              Q3 - $      (28,000)  decreased to $70,000 from $96,000. Reduced
                                                    costs due to reduced regulatory costs.
---------------------------    ------------------   --------------------------------------------------------------------
- Other expenses                   $       72,000   Costs include rent, utilities, and auto related costs.
                              Q3 - $       12,000   Increased from prior year is due to premise costs
                                                    incurred by Datadesk and Lightec.
---------------------------    ------------------   --------------------------------------------------------------------
Increased Selling, general
 & administration expenses         $    1,119,000   S,G&A costs increased to $1,720,000 from
                              Q3 - $      166,000   601,000 in YTD2003 as compared to YTD2002.
---------------------------    ------------------   --------------------------------------------------------------------
Increase (decrease) in loss        $     457,000    Loss  increased  to  $1,304,000  from  $847,000  in
 in nine months ended March                         YTD  2003  as  compared  to  YTD2002
 31st  2003 over 2002 and
 three months ended March     Q3 - $     141,000    Loss increased to $440,000 from $299,000 in Q3-
 31st 2003 and 2002.                                2003 as compared to Q3 - 2002
</TABLE>

At  March  31,  2003,  shareholder  equity  totaled  $5,160,945.

LIQUIDITY  AND  CAPITAL  RESOURCES

During  the  YTD2003  as  compared to YTD2002, our cash flows used in operations
increased  by almost $1,385,000 to $1,922,000 at March 31, 2003 from $537,000 as
at  March  31,  2002.  This  decrease  was due to losses incurred of $1,304,000,
increased  accounts  receivable  of  $175,000,  increased  inventory of $35,000,
reduced  accounts  payable  of $7,000, increased costs and estimated earnings in
excess  of billings on uncompleted contracts of $154,000 and reduced billings in
excess  of  costs  and estimated earning of $477,000, and offset by increases in
accrued  liabilities  and  reduced  prepaid  expenses.

Over  80% of the revenues generated by Lightec in prior years was from one major
contract. In the current year, delays in funding by Lightec's major customer has
resulted  in  a  marked  slow  down  in  revenue  generation  by  Lightec. It is


                                       23
<PAGE>

anticipated  that  the major customer will get its legislated funding during the
current  quarter.

FORWARD  LOOKING  STATEMENTS

The  forgoing  Management's  Discussion  and  Analysis  contain forward -looking
statements  within  the  meaning  of  Rule 175 of the Securities Act of 1933, as
amended,  and  Rule  3b-6  of  the Securities Act of 1934, as amended, including
statements  regarding,  among other items, the Registrant's business strategies,
continued  growth  in  the  Registrant's  markets,  projections, and anticipated
trends  in  the Registrant's business and the industry in which it operates. The
words  believe,  expect,  anticipate,  intends,  forecast,  project, and similar
expression identify forward-looking statements. These forward-looking statements
are  based  largely on the Registrant's expectations and are subject to a number
of  risks  and  uncertainties,  certain  of  which  are  beyond the Registrant's
control.  The  factors that could cause actual results to differ materially form
those  in the forward looking statement, including, among others, the following:
reduced  or lack of increase in demand for the Registrant's products or proposed
products,  competitive  pricing  pressures,  changes  in  the  market  price  of
ingredients used in the Registrant's products and the level of expenses incurred
in  the Registrant's operation. In light of these risks and uncertainties, there
can  be  no assurance that the forward-looking information contained herein will
in  fact  transpire or prove to be accurate. The Registrant disclaims any intent
or  obligation  to  update  forward  looking  statements.


                                       24
<PAGE>

ITEM  3.     CONTROLS  AND  PROCEDURES.

An  evaluation  was  performed,  as of March 31, 2003, under the supervision and
with the participation of our management, including our Chief Financial Officer,
of  the effectiveness of the design and operation of our disclosure controls and
procedures.  Based  on  such  evaluation,  our management has concluded that our
disclosure  controls  and  procedures were effective as of March 31, 2003. There
have  been no significant changes in our internal controls or other factors that
could  significantly  affect our internal controls subsequent to March 31, 2003.


PART  II  -  OTHER  INFORMATION

Item  1.  Legal  Proceedings.

Following  a  proceeding  initiated  by  Edinburgh Investments LLC following the
Company's  default on its debenture, a temporary restraining order by the Clarke
County (Nebraska) court on March 7th 2003.  Concurrently with the signing of the
Memorandum  of  Understanding, Edinburgh Investments LLC and the Company jointly
informed  the  court  that  they  were  suspending  any  further  proceeding.

Item  2.  Changes  in  Securities

During  the third quarter, we issued 988,334 shares of our common stock for cash
proceeds of $138,602 from the private placements.   We believe that the issuance
of such shares did not require registration under the Securities Act of 1933, as
amended,  pursuant to exemptions available under the provisions of Sections 4(2)
and  4(6)  of  the  Securities  Act.

Item  3.  Defaults  on  Senior  Securities.

As  mentioned,  the  Company  has defaulted on its notes to Maryanne Richard and
Synergex,  and  on  its  debentures  to  Librico  Properties  Ltd  and Edinburgh
Investments  LLC.

Item  4.  Submission  of  Matters  to  a  Vote  of  Security  Holders.

None

Item  5.  Other  Information  -  None

Item  No.  6  -  Exhibits  and  Reports  on  Form  8-K

(a)  Exhibits.

Set  forth  below  is  a  list  of the exhibits to this Quarterly Report on Form
10-QSB

Exhibition     Description
  Number

99.1           Certificate of Michel Berty pursuant to 18 U.S.C.1350, as adopted
               pursuant  to  section  906  of  the  Sarbanes-Oxley  Act of 2002.

99.2           Certificate  of  Wayne  Taylor  pursuant  to  18 U.S.C.1350, as
               adopted  pursuant  to  section  906  of the Sarbanes-Oxley Act of
               2002.


(b)  Reports  on  Form  8-K

None


                                       25
<PAGE>

                                   SIGNATURES

In  accordance  with  Section  13  or 15 (d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                  By:  /s/  Michel  Berty
                                  -----------------------
                                  Name:  Michel  Berty
Date:  May  15,  2003             Title: Chairman  and  Chief  Executive Officer

                                  By:  /s/  Wayne  Taylor
                                  -----------------------
                                  Name:  Wayne  Taylor
Date:  May  15,  2003             Title:  Chief  Financial  Officer


                                       26
<PAGE>

                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of Security Biometrics, Inc., (the
"Company")  on  Form  10-QSB  for the nine month period ended March 31, 2003, as
filed  with  the  Securities  and  Exchange  Commission  on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

     1.   The  Report  fully complies with the requirements of Section 13 (a) or
          15  (d)  of  the  Securities  Exchange  Act  of  1934;  and

     2.   The  information  contained  in  the  Report  fairly  presents, in all
          material respects, the financial condition and results of operation of
          the  Company.




Date:  May  15,  2003                          /s/  Michel  Berty
                                               ------------------
                                               Michel  Berty,  Chief  Executive
                                               Officer



                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly Report of Security Biometrics, Inc. \, (the
"Company")  on  Form  10-QSB  for the nine month period ended March 31, 2003, as
filed  with  the  Securities  and  Exchange  Commission  on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

     1.   The  Report  fully complies with the requirements of Section 13 (a) or
          15  (d)  of  the  Securities  Exchange  Act  of  1934;  and

     2.   The  information  contained  in  the  Report  fairly  presents, in all
          material respects, the financial condition and results of operation of
          the  Company.


     Date:  May  15,  2003                   /s/  Wayne  Taylor
                                             ------------------
                                             Wayne  Taylor,  Chief  Financial
                                             Officer


                                       27
<PAGE>